Clinical evaluation of the safety and efficacy of a timosaponin A-III-based antiwrinkle agent against skin aging.
A-Rang ImYoung Kyoung SeoSe Hee ChoKyeong Hee OKi Mo KimSung-Wook ChaePublished in: Journal of cosmetic dermatology (2019)
In conclusion, TA-III could provide protection against photoaging and daily application of TA-III for 12 weeks significantly reduced signs of facial aging by limiting wrinkle formation.